Most Active Stories
- First Look at UT Medical School: New Hospital on Red River, Erwin Center Could Be Demolished
- 'Hate Map' Collects, Charts Texas' Racist, Homophobic Tweets
- Where Else Could Pres. Obama Have Eaten BBQ in Austin?
- A Permanent Farmers Market, and 5 Other Ways Austin Can Become A Foodie Capital
- Last Seen, Moving Slowly, on the UT Campus: a Robotic Couch
KUT News Staff
New UT Cancer Institute To Focus On Drug Research
The University of Texas is committing $75 million to kick start the new Institute for Applied Cancer Science, which will focus on speeding up the discovery and delivery of effective cancer drugs at a time when pharmaceutical companies have scaled back research and development.
Gov. Rick Perry, taking a break from his busy pursuit of the GOP presidential nomination, was on hand for the announcement at the south campus of M.D. Anderson Cancer Center, site of the new facility, in Houston on Monday. Perry said the institute would help Texas cement its position as a leader in cancer research and scientific innovation.
“I believe this state represents a unique crossroads, a place where academic research can come together with a very vibrant private sector to tap into this steadily growing biosciences sector. We’re just scratching the surface of its potential,” Perry said. “We’re creating a culture that will help ensure that great ideas that are born in Texas will stay in Texas, from the laboratory to the marketplace, and then we will export them around the world.”
UT’s MD Anderson will spend a maximum of $15 million a year for five years to help fund the institute. Officials are also trying to raise $42 million in private donations over the same period, and they expect private pharmaceutical companies will contribute research dollars with the hope of investing in the latest cancer remedies.
Dr. Ronald DePinho, president of MD Anderson, led a similar but smaller effort at Harvard University. He said the institute will help fill a void in the cancer drug pipeline, caused by a pullback from pharmaceutical companies and the economic downturn.
“Since about 2003, large Pharma has systematically gutted its early stage research and development and has preserved its capital to fund late-stage clinical development and commercialization,” DePinho said.
He called the creation of the institute, in operation since Sept. 1 but formally announced Monday, a “dark day for cancer.”
The Texas center is taking both inspiration and leadership from Harvard’s Belfer Institute for Applied Cancer Science, part of the renowned Dana-Farber Cancer Institute. DePinho directed the Belfer institute and his wife, Dr. Lynda Chin, was its former scientific director. She will have the same role at the Texas institute.
Former Belfer deputy director Giulio Draetta is now director of the newly created Institute for Applied Cancer Science at MD Anderson.
Perry was introduced at the conference by his top UT appointee, Board of Regents Chairman Gene Powell, who called the governor a “great Texan, a great American.”
Perry, who has a full week ahead on the campaign trail, did not take any questions from reporters at the event. He is staging town-hall events this week in New Hampshire and has private fundraisers scheduled in California.
2012 Presidential Election